Studies have shown the benefits of corticosteroids, such as dexamethasone, in reducing mortality in COVID-19 patients and reducing biomarkers such as ICAM-1 and ANGPT-2 [61,62,63,64]. Here, ANGPT2 is linked to COVID-19.